BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30664534)

  • 1. The Application of FOXO1A Expression Predicts Aggressive Behavior and Poor Prognosis in Gliomas.
    Huang ZY; Hueng DY; Tsai WC
    Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):74-82. PubMed ID: 30664534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
    Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
    Tsai WC; Hueng DY; Nieh S; Gao HW
    J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of TELO2 decreases survival in human high-grade gliomas.
    Feng SW; Chen Y; Tsai WC; Chiou HC; Wu ST; Huang LC; Lin C; Hsieh CC; Yang YJ; Hueng DY
    Oncotarget; 2016 Jul; 7(29):46056-46066. PubMed ID: 27329594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant over-expression of a forkhead family member, FOXO1A, in a brain tumor cell line.
    Dallas PB; Egli S; Terry PA; Kees UR
    BMC Cancer; 2007 Apr; 7():67. PubMed ID: 17442120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of pentraxin 3 and nuclear factor-like 2 implying a relatively longer overall survival time in gliomas.
    Ke HH; Hueng DY; Tsai WC
    Chin J Physiol; 2019; 62(1):35-43. PubMed ID: 30942197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.
    Chen YH; Hueng DY; Tsai WC
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
    Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
    J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of forkhead box protein C2 is related to poor prognosis in human gliomas.
    Wang YW; Yin CL; Zhang HY; Hao J; Yang YY; Liao H; Jiao BH
    Asian Pac J Cancer Prev; 2014; 15(24):10621-5. PubMed ID: 25605149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
    Kao Y; Tsai WC; Chen SH; Hsu SY; Huang LC; Chang CJ; Huang SM; Hueng DY
    Sci Rep; 2021 Sep; 11(1):18541. PubMed ID: 34535705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
    Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J
    Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
    Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
    Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
    Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
    Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of centrosomal proteins at different stages of human glioma.
    Loh JK; Lieu AS; Chou CH; Lin FY; Wu CH; Howng SL; Chio CC; Hong YR
    BMC Cancer; 2010 Jun; 10():268. PubMed ID: 20529377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
    Huang RQ; Shi DL; Huang W; Chen F; Lu YC
    J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
    Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.